Efficacy of remdesivir in Japanese patients hospitalised with COVID-19: A large observational study using the COVID-19 Registry Japan
View ORCID ProfileShinya Tsuzuki, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Hiroshi Ohtsu, Yusuke Asai, Koji Kitajima, Sho Saito, Yukari Uemura, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari
doi: https://doi.org/10.1101/2021.03.09.21253183
Shinya Tsuzuki
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
2Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
Kayoko Hayakawa
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Nobuaki Matsunaga
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
Mari Terada
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Setsuko Suzuki
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Hiroshi Ohtsu
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Yusuke Asai
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
Koji Kitajima
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Sho Saito
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Yukari Uemura
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Taro Shibata
5Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan
Masashi Kondo
6Center for Clinical Trial and Research Support, Fujita Health University, Aichi, Japan
Kazuo Izumi
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Masayuki Hojo
7Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
Tetsuya Mizoue
8Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Kazuhisa Yokota
9Department of Infectious Diseases, Tokyo Metropolitan Health and Medical Corporation Ebara Hospital, Tokyo, Japan
Fukumi Nakamura-Uchiyama
10Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan
Fumitake Saito
11Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan
Wataru Sugiura
4Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
Norio Ohmagari
1AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan
3Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplementary file[supplements/253183_file02.docx]
Posted March 10, 2021.
Efficacy of remdesivir in Japanese patients hospitalised with COVID-19: A large observational study using the COVID-19 Registry Japan
Shinya Tsuzuki, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Hiroshi Ohtsu, Yusuke Asai, Koji Kitajima, Sho Saito, Yukari Uemura, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari
medRxiv 2021.03.09.21253183; doi: https://doi.org/10.1101/2021.03.09.21253183
Efficacy of remdesivir in Japanese patients hospitalised with COVID-19: A large observational study using the COVID-19 Registry Japan
Shinya Tsuzuki, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Hiroshi Ohtsu, Yusuke Asai, Koji Kitajima, Sho Saito, Yukari Uemura, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari
medRxiv 2021.03.09.21253183; doi: https://doi.org/10.1101/2021.03.09.21253183
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)